Laura A. Linynsky
Known title: DirectorCIK: 0001543891
Associated companies
Transaction History
| MD | ▼ Sell | Other | 6,000 | $161K | 9/10/2026 | View on chart |
| MD | ▲ Buy | Grant | 472 | $13K | 8/12/2026 | View on chart |
| MD | ▲ Buy | Grant | 7,196 | $0 | 5/7/2026 | View on chart |
| MD | ▼ Sell | Open Market | 10,000 | $217K | 11/6/2025 | View on chart |
| MD | ▲ Buy | Grant | 11,427 | $0 | 5/8/2025 | View on chart |
| MD | ▼ Sell | Open Market | 7,000 | $78K | 8/27/2024 | View on chart |
| MD | ▲ Buy | Grant | 18,360 | $0 | 5/9/2024 | View on chart |
| MD | ▲ Buy | Grant | 10,965 | $0 | 5/11/2023 | View on chart |
| MD | ▲ Buy | Grant | 8,480 | $0 | 5/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
MD mentioned in list of stocks with questionable fundamentals
Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.
MD mentioned in list of stocks with questionable fundamentals. Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.